• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALIM

ALIM

Alimera Sciences, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD5.54

-0.01 (-0.18%)

Company Profile

CEO

Richard S. Eiswirth Jr.

IPO Date

2019-11-04

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.55

Prev. Close

$5.55

Day Low

$5.53

Day High

$5.56

52W Low

$2.61

52W High

$5.65

Market Cap

$0.30B

Volume

2.68M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

11.7%

Avg Negative

4.1%

Avg Neutral

84.3%

News Feed

Alimera Sciences, Inc. to Present at the Summer Solstice – Best Ideas from the Buy Side Conference on June 2, 2021

GlobeNewsWire·5/27/2021·↑ positive

Alimera Sciences Appoints David Dyer, M.D. as Chief Retina Specialist

GlobeNewsWire·5/17/2021·↑ positive

Alimera Sciences Inc. (ALIM) CEO Rick Eiswirth on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha
·5/1/2021
·↓ negative

Alimera Sciences (ALIM) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research·4/28/2021·↑ positive

Alimera Sciences Announces First Quarter 2021 Financial Results

GlobeNewsWire·4/28/2021·↑ positive

Alimera Sciences to Present at the Zooming with LD Micro Virtual Conference on April 15, 2021

GlobeNewsWire·4/9/2021·↑ positive

Alimera Sciences to Present at the H.C. Wainwright Global Life Sciences Conference

GlobeNewsWire·3/2/2021·↑ positive

Alimera Sciences, Inc. (ALIM) CEO Rick Eiswirth on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/27/2021·↓ negative

Alimera Sciences Reports Fourth Quarter and 2020 Results

GlobeNewsWire·2/24/2021·↓ negative

Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for Both Indications

GlobeNewsWire·2/18/2021·↑ positive